Recent News

• 04.17.2025 - Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience
• 04.17.2025 - Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience
• 04.10.2025 - Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
• 04.10.2025 - Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
• 04.08.2025 - Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference
• 04.08.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.08.2025 - Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference
• 04.01.2025 - Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference
• 04.01.2025 - Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference
• 03.25.2025 - Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians

Recent Filings

• 04.08.2025 - EX-99.1 EX-99.1
• 04.08.2025 - 8-K Current report
• 03.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.07.2025 - 8-K Current report
• 03.07.2025 - 4 Statement of changes in beneficial ownership of securities